{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:41:51Z","timestamp":1791607311096,"version":"4.3.4"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Liver transplantation (LT) for unresectable colorectal liver metastases has long been abandoned because of dismal prognoses. After the dark ages, advances in chemotherapy and diagnostic imaging have enabled strict patient selection, and the pioneering study from the Oslo group has contributed to the substantial progress in this field. For unresectable neuroendocrine liver metastases, LT for patients who met the Milan criteria was able to achieve excellent long-term outcomes. The guidelines further adopted in the United States and Europe were based on these criteria. For hepatoblastoma, patients with unresectable and borderline-resectable disease are considered good candidates for LT; however, the indications are yet to be defined. In the budding era of transplant oncology, it is critically important to recognize the current status and unsolved questions for each disease entity. These guidelines were developed to serve as a beacon of light for optimal patient selection for LT and set the stage for future basic and clinical studies.<\/jats:p>","DOI":"10.1097\/tp.0000000000003118","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T23:03:25Z","timestamp":1585263805000},"page":"1131-1135","source":"Crossref","is-referenced-by-count":49,"title":["Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference"],"prefix":"10.1097","volume":"104","author":[{"given":"Taizo","family":"Hibi","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery and Transplantation, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rela","sequence":"additional","affiliation":[{"name":"Dr. Rela Institute & Medical Centre, Chennai, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Eason","sequence":"additional","affiliation":[{"name":"James D. Eason Transplant Institute, Methodist\/University of Tennessee Hospital, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l-Dag","family":"Line","sequence":"additional","affiliation":[{"name":"Department of Transplantation Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fung","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine Transplant Institute, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seisuke","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Selzner","sequence":"additional","affiliation":[{"name":"Multi-Organ Transplant, Department of Medicine, University of Toronto, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Hong Kong, Hong Kong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"Sherrie and Alan Conover Center for Liver Disease & Transplantation, and Department of Surgery, Weill Cornell Medical College, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sapisochin","sequence":"additional","affiliation":[{"name":"Multi-Organ Transplant, Department of Surgery, University of Toronto, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.surg.2018.10.024","article-title":"What is transplant oncology?","volume":"165","author":"Hibi","year":"2019","journal-title":"Surgery"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"9531925","DOI":"10.1155\/2018\/9531925","article-title":"The new era of transplant oncology: liver transplantation for nonresectable colorectal cancer liver metastases.","volume":"2018","author":"Gorgen","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"74","DOI":"10.21037\/tgh.2018.08.04","article-title":"Transplantation for colorectal metastases: on the edge of a revolution.","volume":"3","author":"Andres","year":"2018","journal-title":"Transl Gastroenterol Hepatol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer.","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1245\/s10434-013-3449-9","article-title":"Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer.","volume":"21","author":"Hagness","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases.","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann Surg"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/ajt.15682","article-title":"Selection criteria related to long term survival following liver transplantation for colorectal liver metastasis.","volume":"20","author":"Dueland","year":"2020","journal-title":"Am J Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/lt.24791","article-title":"Liver transplantation for colorectal liver metastasis: survival without recurrence can be achieved.","volume":"23","author":"Toso","year":"2017","journal-title":"Liver Transpl"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MNM.0000000000000843","article-title":"Importance of 18F-FDG PET\/CT to select patients with nonresectable colorectal liver metastases for liver transplantation.","volume":"39","author":"Grut","year":"2018","journal-title":"Nucl Med Commun"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJMc0904160","article-title":"BRAF mutation in metastatic colorectal cancer.","volume":"361","author":"Tol","year":"2009","journal-title":"N Engl J Med"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jamcollsurg.2019.08.1445","article-title":"Outcomes of resectability assessment of the Dutch Colorectal Cancer Group liver metastases expert panel.","volume":"229","author":"Huiskens","year":"2019","journal-title":"J Am Coll Surg"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ags3.12276","article-title":"How to increase the resectability of initially unresectable colorectal liver metastases: a surgical perspective.","volume":"3","author":"Imai","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhepr.2019.07.004","article-title":"Recent advances in liver transplantation for cancer: the future of transplant oncology.","volume":"1","author":"Abreu","year":"2019","journal-title":"JHEP Rep"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/SLA.0000000000001165","article-title":"A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: the RAPID concept.","volume":"262","author":"Line","year":"2015","journal-title":"Ann Surg"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/SLA.0000000000002861","article-title":"Paradigm shift in the management of irresectable colorectal liver metastases: living donor auxiliary partial orthotopic liver transplantation in combination with two-stage hepatectomy (LD-RAPID).","volume":"270","author":"K\u00f6nigsrainer","year":"2019","journal-title":"Ann Surg"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.surg.2017.05.006","article-title":"Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review.","volume":"162","author":"Moris","year":"2017","journal-title":"Surgery"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","article-title":"Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?","volume":"47","author":"Mazzaferro","year":"2007","journal-title":"J Hepatol"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/ajt.13831","article-title":"The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors.","volume":"16","author":"Mazzaferro","year":"2016","journal-title":"Am J Transplant"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site.","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177lu-dotatate for midgut neuroendocrine tumors.","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","article-title":"Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.","volume":"387","author":"Yao","year":"2016","journal-title":"Lancet"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.28760","article-title":"Therapeutic strategies for neuroendocrine liver metastases.","volume":"121","author":"Frilling","year":"2015","journal-title":"Cancer"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","article-title":"Current concepts in 68ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies.","volume":"58","author":"Bodei","year":"2017","journal-title":"J Nucl Med"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance.","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/TP.0000000000001438","article-title":"Use of everolimus in liver transplantation: recommendations from a working group.","volume":"101","author":"De Simone","year":"2017","journal-title":"Transplantation"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1002\/cncr.26715","article-title":"Surgical management of children with locally advanced hepatoblastoma.","volume":"118","author":"Meyers","year":"2012","journal-title":"Cancer"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","article-title":"Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.","volume":"28","author":"Zs\u00edros","year":"2010","journal-title":"J Clin Oncol"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","article-title":"Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children\u2019s Cancer Group and the Pediatric Oncology Group.","volume":"18","author":"Ortega","year":"2000","journal-title":"J Clin Oncol"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","article-title":"2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT).","volume":"48","author":"Towbin","year":"2018","journal-title":"Pediatr Radiol"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children\u2019s hepatic tumors international collaboration.","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The children\u2019s hepatic tumors international collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10147-013-0616-8","article-title":"Current chemotherapeutic approaches for hepatoblastoma.","volume":"18","author":"Watanabe","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/lt.21586","article-title":"Liver transplantation for hepatoblastoma.","volume":"14","author":"Faraj","year":"2008","journal-title":"Liver Transpl"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.surg.2012.11.006","article-title":"Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities.","volume":"153","author":"Cruz","year":"2013","journal-title":"Surgery"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/lt.23803","article-title":"Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan.","volume":"20","author":"Sakamoto","year":"2014","journal-title":"Liver Transpl"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"e13250","DOI":"10.1111\/petr.13250","article-title":"Long-term outcomes of liver transplantation for hepatoblastoma: a single-center 14-year experience.","author":"Ramos-Gonzalez","year":"2018","journal-title":"Pediatr Transpl"},{"key":"R40-20231002","first-page":"1","article-title":"Hepatoblastoma\u2014the evolution of biology, surgery, and transplantation.","volume":"6","author":"Lim","year":"2018","journal-title":"Children (Basel)"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/cncr.25722","article-title":"Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma.","volume":"117","author":"Lautz","year":"2011","journal-title":"Cancer"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/SLA.0000000000001936","article-title":"POST-TEXT III and IV hepatoblastoma: extended hepatic resection avoids liver transplantation in selected cases.","volume":"266","author":"Fuchs","year":"2017","journal-title":"Ann Surg"},{"key":"R43-20231002","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpedsurg.2009.09.025","article-title":"Outcome of central hepatectomy for hepatoblastomas.","volume":"45","author":"Gu\u00e9rin","year":"2010","journal-title":"J Pediatr Surg"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1097-0142(20001015)89:8<1845::AID-CNCR27>3.0.CO;2-D","article-title":"Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.","volume":"89","author":"Perilongo","year":"2000","journal-title":"Cancer"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2017.73.5654","article-title":"Characterization of pulmonary metastases in children with hepatoblastoma treated on Children\u2019s Oncology Group Protocol AHEP0731 (the treatment of children with all stages of hepatoblastoma): a report from the Children\u2019s Oncology Group.","volume":"35","author":"O\u2019Neill","year":"2017","journal-title":"J Clin Oncol"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology SIOP) study SIOPEL-1 and review of the world experience.","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.23301","article-title":"Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.","volume":"57","author":"H\u00e9ry","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jamcollsurg.2017.02.006","article-title":"Liver transplantation for malignant primary pediatric hepatic tumors.","volume":"225","author":"Khan","year":"2017","journal-title":"J Am Coll Surg"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00383-015-3679-y","article-title":"Navigation using indocyanine green fluorescence imaging for hepatoblastoma pulmonary metastases surgery.","volume":"31","author":"Kitagawa","year":"2015","journal-title":"Pediatr Surg Int"},{"key":"R50-20231002","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/cancers11050730","article-title":"Living donor liver re-transplantation for recurrent hepatoblastoma in the liver graft following complete eradication of peritoneal metastases under indocyanine green fluorescence imaging.","volume":"11","author":"Takahashi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R51-20231002","doi-asserted-by":"crossref","first-page":"e27383","DOI":"10.1002\/pbc.27383","article-title":"Surgical treatment strategy for advanced hepatoblastoma: resection versus transplantation.","volume":"65","author":"Uchida","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamasurg.2015.1847","article-title":"Effect of liver transplant on long-term disease-free survival in children with hepatoblastoma and hepatocellular cancer.","volume":"150","author":"Pham","year":"2015","journal-title":"JAMA Surg"},{"key":"R53-20231002","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2005.02.004","article-title":"Guidelines for surgical treatment of hepatoblastoma in the modern era\u2013recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).","volume":"41","author":"Czauderna","year":"2005","journal-title":"Eur J Cancer"},{"key":"R54-20231002","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/petr.12699","article-title":"Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children\u2019s Hospital.","volume":"20","author":"Kueht","year":"2016","journal-title":"Pediatr Transplant"},{"key":"R55-20231002","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.jpedsurg.2011.09.003","article-title":"Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability.","volume":"46","author":"Ueda","year":"2011","journal-title":"J Pediatr Surg"},{"key":"R56-20231002","first-page":"901","article-title":"Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.","volume":"7","author":"Takayasu","year":"2001","journal-title":"Clin Cancer Res"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T23:10:28Z","timestamp":1722640228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003118","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}